Q4 2019 Holdings
Filed 2020-02-12 | 11 holdings | $137.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Phreesia, Inc. | Common Stock | 71948P106 | $85.6K | 3,214,092 | 62.3% |
| Fate Therapeutics, Inc.(FATE) | Common Stock | 31189P102 | $22.3K | 1,139,783 | 16.2% |
| Cardlytics, Inc.(CDLX) | Common Stock | 14161W105 | $12.6K | 200,000 | 9.1% |
| Selecta Biosciences, Inc.(SELBUSD) | Common Stock | 816212104 | $6.7K | 2,773,479 | 4.8% |
| x4 Pharmaceuticals Inc.(ASNSUSD) | Common Stock | 98420X103 | $3.3K | 311,492 | 2.4% |
| Neuronetics, Inc.(STIM) | Common Stock | 64131A105 | $3.3K | 732,583 | 2.4% |
| Kala Pharmaceuticals, Inc. | Common Stock | 483119103 | $2.1K | 565,289 | 1.5% |
| Atyr Pharma Inc.(LIFEUSD) | Common Stock | 002120103 | $544 | 130,571 | 0.4% |
| Genocea Biosciences, Inc.(GNCAQ) | Common Stock | 372427401 | $509 | 246,078 | 0.4% |
| Pulmatrix, Inc. | Common Stock | 74584P202 | $309 | 359,439 | 0.2% |
| Dare Bioscience, Inc.(CERUEUR) | Common Stock | 23666P101 | $268 | 326,243 | 0.2% |